Hepatitis A IgM, Hepatitis B
Chemiluminescent immunoassay (CLIA)
Red Top Tube
Acceptable Specimen Type(s)
Test Request Form(s)
Varies by test method.
No name on specimen
Healthcare providers should limit use of IgM anti-HAV testing to persons with evidence of clinical hepatitis or to those who have had recent exposure to an HAV-infected person. Use of IgM anti-HAV as a screening tool for asymptomatic persons or as part of testing panels for the workup of non-acute liver function abnormalities is discouraged.
Hepatitis A - Day of receipt
Hepatitis B - 7 days
Hepatitis A provided only for diagnosis of acute illness.
See Hepatitis Criteria Letter for Hepatitis B program requirements.